Victrex PLC Logo

Victrex PLC

ISIN: GB0009292243 | Ticker: VCT | LEI: 213800UYNPHAUNHPXL67
Sector: MaterialsSub-Industry: Specialty Chemicals
Country: United Kingdom

About Victrex PLC

Company Description

Victrex PLC is a leading manufacturer of high-performance polymers and polymer-based solutions. Established in 1993 as a spin-off from Imperial Chemical Industries (ICI), Victrex PLC has become a global leader in the design, development, and production of high-performance polymers used in a wide range of industries.

The company's flagship product is PEEK (polyether ether ketone), a high-performance polymer which is known for its exceptional mechanical, thermal, and chemical properties. PEEK is used in a wide range of applications, including aerospace, automotive, electronics, energy, medical, and industrial.

Victrex PLC is headquartered in the UK, and has operations and sales offices in Europe, the Americas, and Asia. With a workforce of over 900 employees, the company is committed to delivering outstanding results for its customers and stakeholders.

Year founded


Served area





Victrex Technology Centre, Hillhouse International, FY5 4QD Thornton Cleveleys – United Kingdom

Financial statements

Download as Excel
Line item in (gbp) 01.10.2020 01.10.2021 01.10.2022
Assets N/A 615,300,000.00 641,600,000.00
Noncurrent Assets N/A 377,700,000.00 410,000,000.00
Property Plant And Equipment N/A 305,700,000.00 347,200,000.00
Investments In Subsidiaries N/A 0.00 0.00
Investments In Associates N/A 11,400,000.00 10,400,000.00
Deferred Tax Assets N/A 8,900,000.00 7,200,000.00
Noncurrent Financial Assets At Fair Value Through Profit Or Loss N/A 12,700,000.00 10,100,000.00
Noncurrent Recognised Assets Defined Benefit Plan N/A 14,200,000.00 14,900,000.00
Current Assets N/A 237,600,000.00 231,600,000.00
Inventories N/A 70,300,000.00 86,800,000.00
Trade And Other Current Receivables N/A 49,100,000.00 68,100,000.00
Other Current Financial Assets N/A 37,500,000.00 10,100,000.00
Cash and cash equivalents N/A 74,900,000.00 58,700,000.00
Current Derivative Financial Assets N/A 2,900,000.00 0.00
Equity 481,000,000.00 511,700,000.00 490,600,000.00
Issued Capital N/A 900,000.00 900,000.00
Retained Earnings N/A 445,400,000.00 427,200,000.00
Share Premium N/A 61,100,000.00 61,500,000.00
Equity Attributable To Owners Of Parent N/A 509,200,000.00 488,800,000.00
Noncontrolling Interests N/A 2,500,000.00 1,800,000.00
Liabilities N/A 103,600,000.00 151,000,000.00
Noncurrent Liabilities N/A 47,600,000.00 66,400,000.00
Noncurrent Provisions For Employee Benefits N/A 1,900,000.00 2,700,000.00
Deferred Tax Liabilities N/A 31,600,000.00 34,300,000.00
Longterm Borrowings N/A 5,900,000.00 21,600,000.00
Current Liabilities N/A 56,000,000.00 84,600,000.00
Trade And Other Current Payables N/A 49,400,000.00 59,700,000.00
Current Derivative Financial Liabilities N/A 1,900,000.00 19,900,000.00
Line item in (gbp) 01.10.2020/
Revenue 306,300,000.00 341,000,000.00
Profit Loss From Operating Activities 93,400,000.00 88,500,000.00
Finance Income 200,000.00 500,000.00
Finance Costs 200,000.00 300,000.00
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method -900,000.00 -1,000,000.00
Profit Loss Before Tax 92,500,000.00 87,700,000.00
Income Tax Expense Continuing Operations 19,700,000.00 12,200,000.00
Profit (loss) 72,800,000.00 75,500,000.00
Profit Loss Attributable To Owners Of Parent 73,200,000.00 76,200,000.00
Profit Loss Attributable To Noncontrolling Interests -400,000.00 -700,000.00
Line item in (gbp) 01.10.2021 01.10.2022
Profit (loss) 72,800,000.00 75,500,000.00
Adjustments For Decrease Increase In Inventories 26,000,000.00 -13,400,000.00
Adjustments For Sharebased Payments 1,400,000.00 1,800,000.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets 800,000.00 2,400,000.00
Cash Flows From Used In Operations 135,500,000.00 90,700,000.00
Interest Paid Classified As Operating Activities 0.00 400,000.00
Interest Received Classified As Operating Activities 200,000.00 300,000.00
Cash Flows From Used In Operating Activities 127,100,000.00 80,000,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities 41,900,000.00 45,500,000.00
Cash Advances And Loans Made To Other Parties Classified As Investing Activities 3,800,000.00 2,300,000.00
Dividends Received Classified As Investing Activities 0.00 0.00
Cash Flows From Used In Investing Activities -83,200,000.00 -16,200,000.00
Proceeds From Issuing Shares 6,100,000.00 400,000.00
Proceeds From Borrowings Classified As Financing Activities 0.00 14,500,000.00
Payments Of Lease Liabilities Classified As Financing Activities 1,800,000.00 2,100,000.00
Dividends Paid Classified As Financing Activities 51,600,000.00 95,200,000.00
Cash Flows From Used In Financing Activities -41,700,000.00 -82,400,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2,200,000.00 -18,600,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents -400,000.00 2,400,000.00
Cash and cash equivalents 74,900,000.00 58,700,000.00

Please note that some sums might not add up.

Filings & Publications


Consolidated Report
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Short Interest

Current short interest

Position Holder Short Interest in Percent Date
Millennium Capital Partners LLP 0.78% 19.10.23
Millennium Capital Partners LLP 0.58% 28.07.23
Millennium Capital Partners LLP 0.81% 01.11.23
Millennium Capital Partners LLP 0.80% 20.10.23
Millennium Capital Partners LLP 0.70% 05.10.23
Millennium Capital Partners LLP 0.71% 13.09.23
Millennium Capital Partners LLP 0.69% 18.09.23
Millennium Capital Partners LLP 0.60% 17.08.23
Millennium Capital Partners LLP 0.69% 07.09.23
Total 6.36%

Capital markets information







Industry Group





Specialty Chemicals

Listed Stock Exchange

London Stock Exchange

Stock Index

FTSE 250

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.